BB Good human data, but mixed outcomes or surrogate markers. How we grade →Randomized controlled trial (double-blind) · 311 adults aged 55 to 70, 3 years
Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial
LA Burt, EO Billington, MS Rose, DA Raymond, DA Hanley, SK Boyd. JAMA. 2019.
Bottom line: In healthy adults aged 55 to 70, 3 years of 4,000 or 10,000 IU daily vitamin D lowered bone density more than 400 IU, without improving bone strength.
- In plain language
- In this 3-year double-blind trial in Calgary, Canada, 311 healthy adults aged 55 to 70 without osteoporosis took 400, 4,000 or 10,000 IU of vitamin D3 daily. Compared with 400 IU, radius bone density fell more with 4,000 IU (3.9 mg HA/cm3 lower) and 10,000 IU (7.5 mg HA/cm3 lower), with average losses of 1.2%, 2.4% and 3.5% in the three groups. Tibia bone density was significantly lower only with 10,000 IU. Bone strength did not differ between groups, and mild high calcium levels were more common at the higher doses.
- Limits
- Outcomes were bone scans and estimated strength, not fractures, and participants were mostly vitamin D replete at the start, so results may not apply to people with deficiency or osteoporosis. It was a single-center study funded by the Pure North S'Energy Foundation, which had no role in design or analysis.
- Which of our grades it feeds
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Science summary: Vitamin D testing and dose: what your 25(OH)D number means, how much D3 moves it, and why more is not better
- DD Mostly mechanistic or early data. Shown openly. How we grade →Graded claim: Vitamin D3 (in the multivitamin): Bone health when your level is low
- DD Mostly mechanistic or early data. Shown openly. How we grade →Ratings card: Vitamin D3 (in the multivitamin): Bone health and normal immune function when your level is low (two claim rows, both D)
- Source
- doi.org/10.1001/jama.2019.11889 · PubMed 31454046 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. Reviewed . We sell some of what we grade.